Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Vor Biopharma Inc. (VOR : NSDQ)
 
 • Company Description   
Vor Biopharma Inc. is a cell therapy company pioneering engineered hematopoietic stem cell therapies combined with targeted therapies for the treatment of cancer. Vor Biopharma Inc. is based in CAMBRIDGE, Mass.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $20.10 Daily Weekly Monthly
20 Day Moving Average: 94,887 shares
Shares Outstanding: 37.13 (millions)
Market Capitalization: $746.35 (millions)
Beta:
52 Week High: $63.62
52 Week Low: $18.11
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.38% -5.41%
12 Week -53.36% -56.32%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
-
-
-,- -
-
ph: -
fax: -
None None
 
 • General Corporate Information   
Officers
- - -
- - -
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 929033108
SIC: -
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/05/21
Share - Related Items
Shares Outstanding: 37.13
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $746.35 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.47 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.18 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/21 - -
12/31/20 - -
09/30/20 - -
ROA
03/31/21 - -
12/31/20 - -
09/30/20 - -
Current Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - -
Quick Ratio
03/31/21 - -
12/31/20 - -
09/30/20 - -
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Book Value
03/31/21 - -
12/31/20 - -
09/30/20 - -
Inventory Turnover
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Equity
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Capital
03/31/21 - -
12/31/20 - -
09/30/20 - -
 

Powered by Zacks Investment Research ©